Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Trautmann

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Oncogene|October 31, 2006
Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activityD T Starczynowski, H Trautmann, C Pott, et al.
Leukemia|December 18, 2013
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersM Ladetto, M Brüggemann, L Monitillo, et al.
Leukemia|July 17, 2014
Genomic and epigenomic co-evolution in follicular lymphomasM Loeffler, M Kreuz, A Haake, et al.
Leukemia|April 5, 2023
The KMT2A recombinome of acute leukemias in 2023C Meyer, P Larghero, B Almeida Lopes, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Oncogene|October 31, 2006
Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activityD T Starczynowski, H Trautmann, C Pott, et al.
Leukemia|December 18, 2013
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersM Ladetto, M Brüggemann, L Monitillo, et al.
Leukemia|July 17, 2014
Genomic and epigenomic co-evolution in follicular lymphomasM Loeffler, M Kreuz, A Haake, et al.
Leukemia|April 5, 2023
The KMT2A recombinome of acute leukemias in 2023C Meyer, P Larghero, B Almeida Lopes, et al.
Pageof 3